Cancer in young people is rare, but it is still a major health issue in Europe. Each year, more than 6,000 young people in Europe die of cancer. There are more than 300,000 European childhood cancer survivors (in 2020, they will be nearly half a million): two-thirds of them have some late side effects of treatment, that are severe and impact on the daily life of half of those affected.
Within the European Network for Cancer research in Children and Adolescents (ENCCA), SIOPE and the European paediatric haematology-oncology community have established a longterm sustainable Strategic Plan to increase the cure rate and the quality of survivorship for children and young people with cancer over the next ten years. The ultimate goal is to increase the disease- and late-effect- free survival after 10 years from the disease, and beyond.
Dieser Artikel bietet ausschließlich informative Unterstützung und ersetzt keine professionelle medizinische Beratung, Diagnose oder Behandlung. Wenden Sie sich bei medizinischen Entscheidungen stets an Ihre Ärztin/Ihren Arzt.
Dieser Inhalt wurde im Rahmen des Projekts EU-CAYAS-NET erstellt, das in den Jahren 2022-2025 durch das EU4Health-Programm kofinanziert wurde (Finanzhilfevereinbarung Nr. 101056918).
